アミノアラビノストランスファーゼ (ArnT) の構造は,脂質Aグリコシル化のための分子基盤を示唆する
Vasileios I Petrou1, Carmen M Herrera2, Kathryn M Schultz3
1Department of Physiology and Cellular Biophysics, Columbia University, New York, NY 10032, USA.
まとめ
グラム陰性細菌におけるポリミキシン耐性にとって重要な酵素であるArnTの構造的な洞察は,それが細菌の外膜をどのように変化させるかを明らかにする. このメカニズムの理解は 多剤耐性感染症に対する新しい戦略の開発に不可欠です
科学分野:
- 微生物学
- 構造生物学
- 生物化学
背景:
- ポリミキシンは,グラム陰性細菌に対する重要な最後の抗生物質です.
- ポリミキシンに対する耐性は,細菌の外膜の脂質Aの改変を含みます.
- この変異は,4-アミノ-4-デオキシ-L-アラビノース移転酶 (ArnT) によって触媒化されます.
研究 の 目的:
- ArnT活動の構造的基盤を明らかにする.
- ArnTによる脂質基板結合と触媒の仕組みを理解する.
- 新しい抗感染戦略を設計するための基盤を提供すること.
主な方法:
- クープリアヴィドゥス・メタルリドゥランスのArnTのX線結晶学.
- 単体およびアンデカプレニルリン酸と複合した結晶構造の決定.
- 構造データに基づいた機能的変異性研究
主要な成果:
- ArnTの結晶構造は2. 8と3.2アングストームの解像度で決定された.
- 構造は活性部位に収束する脂質基板のための明確な空洞を明らかにした.
- アンデカプレニルフォスファート結合は構造的再配置を誘導し,リピドA相互作用の活性部位を安定させます.
結論:
- 構造は,ArnT媒介の脂質A変異の詳細なメカニズムモデルを提供します.
- この研究は,ポリミキシン抗生物質に対する重要な耐性メカニズムに光を当てています.
- この発見は,多剤耐性グラム陰性細菌の感染と戦うための潜在的な標的を提供している.
関連する概念動画
Oligosaccharide Assembly
3.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.8K
Formation of Lipopolysaccharides
916
Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
916
Lipids as Anchors
7.9K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
7.9K
Protein Glycosylation
10.4K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
10.4K
Biosynthesis of Lipids
856
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis...
856
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
66
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
66


